Rapid Test Kits for Clozapine and other drugs

The Trust currently has a requirement for rapid test kits to detect Clozapine. Treatment of Schizoaffective disorder with antipsychotics requires regular monitoring of blood concentrations to ensure that treatment is safe and effective. At present, this involves collecting venous blood samples and sending these to a laboratory for analysis. Some patients dislike venous blood sampling, clinicians may be reluctant to use certain antipsychotics because of the associated logistical demands, and there is a delay before the results become available.

With the advent of novo technologies which allow for rapid antipsychotic concentration measurements at the point of care by fingerstick capillary blood methods we would like to find a suitable supplier to support transition to such a testing platform.

We publish all our open sourcing requirements via the "Health Family Single eCommercial System" portal.

https://health-family.force.com/s/Welcome

This is used by many organisations across the NHS and wider Health System to manage tendering and contract management activity. By registering on the system you will be able to see opportunities across all these organisations.